Literature DB >> 20737059

Urinary incontinence in the elderly: part 3 of a series of articles on incontinence.

Mark Goepel1, Ruth Kirschner-Hermanns, Annette Welz-Barth, Klaus-Christian Steinwachs, Herbert Rübben.   

Abstract

BACKGROUND: Urinary incontinence is a common and distressing complaint in the elderly. Its causes include structural changes in vesical muscle as well as impaired neural control and age-related changes of the lower urinary tract. Incontinence can also be a side effect of medication.
METHODS: The PubMed database was selectively searched for publications containing the terms "urinary incontinence" and "elderly." Studies with a high level of evidence were chosen as the main basis for this review.
RESULTS: The individualized diagnostic evaluation of the incontinent elderly patient should generally be non-invasive. The evaluation may reveal urinary incontinence of several different types: stress incontinence, overactive bladder, and mixed incontinence. The treatment generally involves medication, such as anti-muscarinic agents, alpha-receptor blockers, and/or serotonin/noradrenalin reuptake inhibitors, combined with modifications of personal behavior, such as bladder training, altered fluid intake, and pelvic floor contraction. A number of minimally invasive surgical techniques can be useful for patients in operable condition, whenever such an operation seems reasonable in view of the patient's overall situation.
CONCLUSION: Urinary incontinence in the elderly can be readily evaluated, and the currently available forms of treatment often bring satisfactory relief with an economical use of medical resources and with little or no additional discomfort for the patient.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20737059      PMCID: PMC2925344          DOI: 10.3238/arztebl.2010.0531

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN: 1866-0452            Impact factor:   5.594


  20 in total

Review 1.  Anticholinergic side-effects of drugs in elderly people.

Authors:  J Mintzer; A Burns
Journal:  J R Soc Med       Date:  2000-09       Impact factor: 5.344

Review 2.  Antimuscarinics for treatment of overactive bladder.

Authors:  Karl-Erik Andersson
Journal:  Lancet Neurol       Date:  2004-01       Impact factor: 44.182

3.  Influences of trospium chloride and oxybutynin on quantitative EEG in healthy volunteers.

Authors:  A Pietzko; W Dimpfel; U Schwantes; P Topfmeier
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

4.  Structural basis of geriatric voiding dysfunction. I. Methods of a prospective ultrastructural/urodynamic study and an overview of the findings.

Authors:  A Elbadawi; S V Yalla; N M Resnick
Journal:  J Urol       Date:  1993-11       Impact factor: 7.450

5.  Structural basis of geriatric voiding dysfunction. IV. Bladder outlet obstruction.

Authors:  A Elbadawi; S V Yalla; N M Resnick
Journal:  J Urol       Date:  1993-11       Impact factor: 7.450

6.  Structural basis of geriatric voiding dysfunction. II. Aging detrusor: normal versus impaired contractility.

Authors:  A Elbadawi; S V Yalla; N M Resnick
Journal:  J Urol       Date:  1993-11       Impact factor: 7.450

7.  Structural basis of geriatric voiding dysfunction. III. Detrusor overactivity.

Authors:  A Elbadawi; S V Yalla; N M Resnick
Journal:  J Urol       Date:  1993-11       Impact factor: 7.450

8.  Duloxetine versus placebo in the treatment of stress urinary incontinence.

Authors:  Peggy A Norton; Norman R Zinner; Ilker Yalcin; Richard C Bump
Journal:  Am J Obstet Gynecol       Date:  2002-07       Impact factor: 8.661

9.  Prevalence and physician awareness of symptoms of urinary bladder dysfunction.

Authors:  Mark Goepel; Josef A Hoffmann; Maria Piro; Herbert Rübben; Martin C Michel
Journal:  Eur Urol       Date:  2002-03       Impact factor: 20.096

10.  SPET imaging of central muscarinic receptors with (R,R)[123I]-I-QNB: methodological considerations.

Authors:  R Norbury; M J Travis; K Erlandsson; W Waddington; J Owens; P J Ell; D G Murphy
Journal:  Nucl Med Biol       Date:  2004-07       Impact factor: 2.408

View more
  7 in total

1.  Recurrent hyponatremia due to tolterodine.

Authors:  Ihsan Ustun; Mürsel Davarcı; Onur Demirbaş; Nilgul Ustun; Cumali Gokce
Journal:  Can Urol Assoc J       Date:  2012-06       Impact factor: 1.862

Review 2.  Improving the health care of geriatric patients: management of urinary incontinence: a position paper.

Authors:  K Becher; M Oelke; B Grass-Kapanke; J Flohr; E A Mueller; U Papenkordt; B Schulte-Frei; K-C Steinwachs; S Süss; M Wehling
Journal:  Z Gerontol Geriatr       Date:  2013-07       Impact factor: 1.281

Review 3.  Pharmacological Treatment of Post-Prostatectomy Incontinence: What is the Evidence?

Authors:  Anja Løvvik; Stig Müller; Hitendra R H Patel
Journal:  Drugs Aging       Date:  2016-08       Impact factor: 3.923

4.  Factors Related to Urinary Incontinence among the Malaysian Elderly.

Authors:  S A Eshkoor; T A Hamid; S Shahar; C Y Mun
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

5.  Characterization of gap junction proteins in the bladder of Cx43 mutant mouse models of oculodentodigital dysplasia.

Authors:  R Lorentz; Q Shao; T Huang; G I Fishman; D W Laird
Journal:  J Membr Biol       Date:  2012-07-03       Impact factor: 1.843

6.  Self-perceived health and functional status of older people: Telephone-based lifestyle survey of older adults in Tehran province.

Authors:  Masoumeh Sadeghipour Rousari; Moloud Payab; Sahar Keyvanloo Shahrestanaki; Mahbube Ebrahimpur; Neda Mehrdad; Solmaz Sadat Naghavi Alhosseini; Faranak Bidmeshgipour; Hossein Adibi; Amirali Safari Astaraei; Raziye Sadat Hosseini; Bagher Larijani; Farshad Sharifi
Journal:  Health Promot Perspect       Date:  2022-05-29

7.  The biofeedback therapy in patients with stress incontinence urinary.

Authors:  Maria Thereza Micussi
Journal:  Nephrourol Mon       Date:  2012-06-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.